Form 4 for LFMD LifeMD, Inc.

Accepted 2024-08-20 00:00:00 ET · period of report 2022-04-04 · accession 0000912282-24-000578 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2024-08-20	2022-04-04+	LFMD	Wijnker Dennis	CTO	A - Grant	—	+100.0K	20.0K	New	—
D	2024-08-20	2024-08-18	LFMD	Wijnker Dennis	CTO	D - Sale to Iss	—	-80.0K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-08-18	A	A	80,000	—	100,000	D	—	—	(F2) The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.
2	Common	Common Stock	2022-04-04	A	A	20,000	—	20,000	D	—	—	(F1) The restricted shares vest in full on April 4, 2025.
3	Derivative	Stock Option (Right to Buy)	2024-08-18	D	D	80,000	—	0	D	$3.78 · — to —	80,000 Common Stock	(F2) The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.